Alphatec Spine to Showcase New Minimally Invasive (MIS) and Complex Spine Products at the Upcoming 31st Annual North American Spine Society (NASS) Meeting in Boston

CARLSBAD, Calif., Oct. 18, 2016 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that it will introduce several new products, as well as its current comprehensive portfolio at the upcoming North American Spine Society (NASS) meeting at the Boston Convention and Exhibition Center in Boston, Massachusetts, which will be held from October 26th – 29th, 2016.  Alphatec Spine will be located in booth number 1523.  In addition, today the Company announced that it has received 510(k)…

Read More

Kessler Foundation seeks participants for research studies

EAST HANOVER, N.J., Oct. 18, 2016 (GLOBE NEWSWIRE) — Kessler Foundation is recruiting study participants for multiple research programs aimed at improving cognition, mobility, and long-term outcomes for people with disabling injuries and illnesses, including cancer, multiple sclerosis, spinal cord injury, stroke, and traumatic brain injury. By participating in the Foundation’s rehabilitation research, you’ll help improve the lives of people with disabilities and their loved ones. Study participants are typically compensated for their time, and may have a chance to try new therapies and technologies. On a case-by-case basis, Foundation…

Read More

Myriad Genetics Teams Up with Project BioEYES to Advance STEM Education in Utah

SALT LAKE CITY, Oct. 18, 2016 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that more than 40 of its employees are volunteering to support Project BioEYES, which is a science, technology, engineering and math (STEM) education program designed to teach K-12 students about cell biology, genetics and careers in science. Employees will spend a day in the classroom helping students formulate scientific hypotheses, design experiments and collect data, as well as sharing their own experiences from working in the life…

Read More

Cancer Support Community Applauds White House in Release of Cancer Moonshot Task Force Report

WASHINGTON, Oct. 17, 2016 (GLOBE NEWSWIRE) — The Cancer Support Community, an international nonprofit, was pleased to participate today in the White House’s release of the Cancer Moonshot Task Force Report, which outlines a detailed set of findings and recommendations to achieve the goals established for the Cancer Moonshot initiative earlier this year. Cancer Support Community CEO Kim Thiboldeaux also participated in a Q&A Twitter chat in the evening to answer questions on the initiative, along with Cancer Moonshot’s Greg Simon, U.S. Secretary of Energy Ernest Moniz, National Institutes of…

Read More

The American College of Prosthodontists Installs Dr. Stephen D. Campbell as Board Member for the ACP Council for the American Board of Prosthodontics

CHICAGO, Oct. 17, 2016 (GLOBE NEWSWIRE) — Dr. Stephen D. Campbell, DDS, MMS, FCAP, has been installed as a board member for the American College of Prosthodontists Council for the American Board of Prosthodontics. Dr. Campbell was sworn in during the 46th Annual Session of the ACP held in San Diego from Oct. 5-8, 2016. Dr. Campbell is a past president of the College of Prosthodontists, and received a Presidential Citation from the ACP in 2015. He is currently the Professor and Head of Restorative Dentistry, as well as Director…

Read More

Myriad Will Present New Data on Its Variant Classification Program at the ASHG Annual Meeting

SALT LAKE CITY, Oct. 17, 2016 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced it will present four new studies at the American Society of Human Genetics Annual Meeting being held Oct. 18-22, 2016 in Vancouver, British Columbia. The research being presented highlights the clinical utility of Myriad’s myVision® Variant Classification Program and myRisk Hereditary Cancer gene panel test.  “Precision medicine is dependent on the accuracy of the information being provided to patients, and Myriad’s myVision is the most advanced variant…

Read More

Talyst to Exhibit at the AHCA/NCAL Annual Conference

KIRKLAND, Wash., Oct. 13, 2016 (GLOBE NEWSWIRE) — The Talyst Long-Term Care Division, a leader in automated medication management for skilled nursing facilities, will be participating in the American Health Care Association/National Center for Assisted Living 2016 Annual Conference in Nashville, TN on October 17-18. Talyst LTC will be exhibiting in booth #269, where it will be showcasing its medication management automation technology as well as promoting its online long-term care nursing Continuing Education platform, TCIP University. “We are excited to share our ideas and innovative technologies with attendees of…

Read More

Miracle Flights Among Charities Nominated to Win $25,000 in TeamHealth Cares Event

LAS VEGAS, Oct. 13, 2016 (GLOBE NEWSWIRE) — Miracle Flights has been selected as one of five nonprofits entered to receive a $25,000 donation from national healthcare leader, TeamHealth. The charity, which recently celebrated its 100,000 flight milestone, provides free commercial airline tickets to patients in need of long-distant medical care. TeamHealth is the country’s leading provider of outsourced hospital-based clinical and administrative services. The group will host its TeamHealth Cares event next week in Las Vegas as a part of its valued tradition of charity and community stewardship. TeamHealth…

Read More

Kantar Health Launches New Oncology Platform, Allowing Healthcare Companies to Better Understand Drug Opportunities

NEW YORK, Oct. 13, 2016 (GLOBE NEWSWIRE) — Kantar Health, a leading global healthcare consulting and market research firm, today announced the launch of CancerLandscape™, offering fast navigation of large datasets to better understand oncology drug opportunities and the competitive landscape. This new solution can assist users in evaluating business development and licensing opportunities, identifying novel targets for drug development, comparing company pipelines, and understanding the competitive landscapes in multiple tumor types. “For the first time, we’ve aggregated multiple data sources to achieve unprecedented insight that will help identify the…

Read More

BioSig Technologies to Present at the Dawson James 2016 Small Cap Growth Stock Conference

Minneapolis, MN, Oct. 12, 2016 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP) signal acquisition and analysis system, today announced that its Executive Chairman, Mr. Kenneth Londoner will present at the Dawson James 2016 Small Cap Growth Stock Conference.  The Conference will be held on October 20, 2016 at the Wyndham Grand Hotel in Jupiter, Florida. Event:  Dawson James 2016 Small Cap Growth Stock Conference Location: Wyndham Grand Hotel, Jupiter, Florida Time: Thursday, October 20th at 8:30am in…

Read More